Characterization and Clinical Outcomes of Severe Asthma Patients in Israel Treated With Benralizumab (SAIL-B)
Clinical trial NCT07218172 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07218172
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-03-24
- Primary completion
- 2026-11-30
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.